|274.20||-1.32||-0.48%||Vol 1.07M||1Y Perf -51.58%|
|May 16th, 2022 16:00 DELAYED|
|- -||-0.70 -0.26%|
|Target Price||492.22||Analyst Rating||Strong Buy 1.44|
|Potential %||79.51||Finscreener Ranking||★★★+ 50.55|
|Insiders Trans % 3/6/12 mo.||100/100/-97||Value Ranking||★★+ 48.33|
|Insiders Value % 3/6/12 mo.||100/100/-96||Growth Ranking||★★★★+ 66.90|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/-91||Income Ranking||— -|
|Price Range Ratio 52W %||4.84||Earnings Rating||Strong Sell|
|Market Cap||21.61B||Earnings Date||27th Apr 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.99|
|EPS Growth Next 5 Years %||7.20|
|Avg. Weekly Volume||1.35M|
|Avg. Monthly Volume||1.28M|
|Avg. Quarterly Volume||923.67K|
Align Technology Inc. (NASDAQ: ALGN) stock closed at 274.2 per share at the end of the most recent trading day (a -0.48% change compared to the prior day closing price) with a volume of 1.07M shares and market capitalization of 21.61B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 21590 people. Align Technology Inc. CEO is Joseph M. Hogan.
The one-year performance of Align Technology Inc. stock is -51.58%, while year-to-date (YTD) performance is -58.28%. ALGN stock has a five-year performance of 101.5%. Its 52-week range is between 250.64 and 737.452, which gives ALGN stock a 52-week price range ratio of 4.84%
Align Technology Inc. currently has a PE ratio of 31.00, a price-to-book (PB) ratio of 5.92, a price-to-sale (PS) ratio of 5.36, a price to cashflow ratio of 22.50, a PEG ratio of 2.32, a ROA of 13.16%, a ROC of 19.36% and a ROE of 20.55%. The company’s profit margin is 17.49%, its EBITDA margin is 26.30%, and its revenue ttm is $4.03 Billion , which makes it $51.15 revenue per share.
Of the last four earnings reports from Align Technology Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.99 for the next earnings report. Align Technology Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Align Technology Inc. is Strong Buy (1.44), with a target price of $492.22, which is +79.51% compared to the current price. The earnings rating for Align Technology Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Align Technology Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Align Technology Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.78, ATR14 : 21.22, CCI20 : -61.68, Chaikin Money Flow : -0.03, MACD : -39.03, Money Flow Index : 37.23, ROC : -10.00, RSI : 31.81, STOCH (14,3) : 18.36, STOCH RSI : 0.97, UO : 40.02, Williams %R : -81.64), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Align Technology Inc. in the last 12-months were: Andrea L. Saia (Option Excercise at a value of $0), Andrea L. Saia (Sold 2 000 shares of value $1 218 411 ), Anne M. Myong (Option Excercise at a value of $0), Charles Raymond Larkin (Option Excercise at a value of $0), Charles Raymond Larkin (Sold 7 500 shares of value $4 875 000 ), Emory Wright (Option Excercise at a value of $0), Emory Wright (Sold 5 124 shares of value $3 620 495 ), George J. Morrow (Option Excercise at a value of $0), George J. Morrow (Sold 5 000 shares of value $3 536 682 ), Greg J. Santora (Option Excercise at a value of $0), Greg J. Santora (Sold 2 500 shares of value $1 753 337 ), John F Morici (Option Excercise at a value of $0), John F Morici (Sold 19 726 shares of value $12 397 846 ), Joseph A. Lacob (Option Excercise at a value of $0), Joseph M. Hogan (Buy at a value of $1 999 842), Joseph M. Hogan (Option Excercise at a value of $0), Joseph M. Hogan (Sold 66 667 shares of value $46 636 431 ), Julie Ann Coletti (Option Excercise at a value of $0), Julie Ann Coletti (Sold 1 564 shares of value $1 110 440 ), Kevin J. Dallas (Option Excercise at a value of $0), Stuart A. Hockridge (Option Excercise at a value of $0), Stuart A. Hockridge (Sold 18 572 shares of value $13 068 371 ), Susan E. Siegel (Option Excercise at a value of $0), Thomas M. Prescott (Option Excercise at a value of $0), Warren S. Thaler (Option Excercise at a value of $0), Warren S. Thaler (Sold 15 000 shares of value $10 093 024 )
Sun, 17 Apr 2022 12:36 GMT Analysts Top Healthcare Picks: Align Tech (ALGN), Amarin (AMRN)- TipRanks. All rights reserved.
Wed, 30 Mar 2022 02:25 GMT Analysts Are Bullish on Top Healthcare Stocks: Align Tech (ALGN), Karyopharm Therapeutics (KPTI)- TipRanks. All rights reserved.
Fri, 25 Mar 2022 12:35 GMT Analysts Conflicted on These Healthcare Names: Align Tech (ALGN), Vaxxinity Inc (VAXX) and Moderna (MRNA)- TipRanks. All rights reserved.
Tue, 22 Mar 2022 14:05 GMT Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Nkarta (NKTX)- TipRanks. All rights reserved.
Thu, 10 Feb 2022 02:05 GMT Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Becton Dickinson (BDX) and Biogen (BIIB)- TipRanks. All rights reserved.
Mon, 07 Feb 2022 18:19 GMT Align Technology: Solid Company, Analysts See 30% Upside- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.